DeepIntent, a leading healthcare advertising technology company built to influence better patient health and business outcomes, announced the appointment of Amit Chaturvedi as its first Chief Operating Officer.
As DeepIntent's first Chief Operating Officer, Chaturvedi will be responsible for the overall business operations of DeepIntent and report directly to the company's founder and Chief Executive Officer, Chris Paquette. Chaturvedi's primary focus will be further integrating and scaling DeepIntent's sales, campaign management, client success & business development teams as the company executes on its plan to further define itself as the leading platform for digital advertising in healthcare.
Chaturvedi joins DeepIntent with more than two decades of operating experience in advertising technology startups and global media companies. In his last role as Executive Vice President of Revenue Operations & Product at WarnerMedia, Chaturvedi led the company's linear and digital revenue operations functions and was accountable for unifying cross-platform revenue offerings and strategy with a particular emphasis on advanced digital solutions, including CTV and audience solutions. During his tenure, revenues grew over 10x with total revenue under management exceeding $5 billion annually. Chaturvedi also previously served as COO of Taykey, a Sequoia and Softbank-backed startup that was acquired by global connected TV (CTV) leader Innovid in 2017, with prior experiences including leadership roles at aQuantive (acquired by Microsoft), IAC/InterActiveCorp, and QualityHealth (acquired by Sharecare).
Trends in Continuing Medical Education
April 12th 2024Elliott Yoo, Senior Media Strategist at epocrates, takes a closer look at the trends in CME consumption and what the future of medical education will be – from the priorities for physicians as they juggle learning with patient care, to what type of activities resonate most with prescribers.
Transforming Cancer Care: Data, AI, and Patient-Centered Care
July 20th 2023Join us as Mohit Manrao, SVP and head of US oncology at AstraZeneca, shares his patient-centered approach to transforming cancer care, bridging the gap between innovative science and tangible patient outcomes across all populations on a global scale.